Daniela Weber

Daniela Weber, Ph.D., M.Sc., is a Research Associate at the University Clinic for Pediatrics and Adolescent Medicine and the Research Program for Receptor Biochemistry and Tumor Metabolism at Paracelsus Medical University. Her research spans the intersection of biochemistry, immunology, and cancer research with expertise in epigenetic biomarkers, metabolomics, and molecular diagnostics for clinical applications.

Her primary research interests include:

• Epigenetic signatures for cancer risk assessment and prevention
• Metabolomic analysis of disease states including cancer and neurological disorders
• Biomarker discovery for migraine diagnosis through skin analysis
• Development of analytical methods for drug quantification and metabolic profiling

Dr. Weber's recent publications demonstrate significant contributions to epigenetic clocks for cancer detection, analytical methodology development, and biomarker research. Her work shows a clear trajectory toward translating basic research findings into clinical applications, particularly in personalized medicine and diagnostic development.

She actively contributes to collaborative research as Co-Principal Investigator on the 'Establishment of biomarkers for migraine in the skin' project (2024-2027) and previously led the 'Metabolomics analysis of human plasma samples to identify diagnostic biomarkers for melanoma' project (2022-2023).

Dr. Weber serves on the Scientific Advisory Board for the 'Conference on Ketogenic Nutritional Therapies - from Empiricism to Evidence' (November 2024), demonstrating her engagement with the broader scientific community and commitment to evidence-based medical approaches.